Jan. 16, 2024: FDA conducts inspection at CellTrans, Inc. in Chicago
On January 16, 2024, the Food and Drug Administration conducted an inspection of CellTrans, Inc. in Chicago, focusing on human cellular, tissue, and gene therapies, according to information available on the FDA’s website.


















